B Cell Acute Lymphoblastic Leukemia (all) - Genetic Mutations

Relevant Publications

Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia.

Issue Release: 2025

Genomic and Clinicopathological Characterization of CRLF2-Rearranged Mixed Phenotype Acute Leukemia.

Issue Release: 2025

Hyper-CVAD and Sequential Blinatumomab Without and With Inotuzumab in Young Adults With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.

Issue Release: 2025

Clinicopathological differences between T-lymphoblastic leukemia/lymphoma, early T-precursor lymphoblastic leukemia/lymphoma, and mixed-phenotype acute leukemia with T lineage: an analysis of 41 adult cases.

Issue Release: 2024

Expression of VISTA regulated via IFN-γ governs endogenous T-cell function and exhibits correlation with the efficacy of CD19 CAR-T cell treated B-malignant mice.

Issue Release: 2024

Tumor-Suppressive Cross-Linking of Anti- Antibodies in Acute Lymphoblastic Leukemia.

Issue Release: 2024

An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR-ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia.

Issue Release: 2024

CAR-T Cells in Chronic Lymphocytic Leukemia.

Issue Release: 2024

Real-world evidence on treatment pattern, effectiveness, and safety of blinatumomab in Chinese patients with B-cell acute lymphoblastic leukemia.

Issue Release: 2024

Advances in the treatment of adults with newly diagnosed B-cell acute lymphoblastic leukemia: the role of frontline immunotherapy-based regimens.

Issue Release: 2024

Glucocorticoids paradoxically promote steroid resistance in B cell acute lymphoblastic leukemia through CXCR4/PLC signaling.

Issue Release: 2024

Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non-high-risk acute lymphoblastic leukemia treated according to the ALL-MB 2008 protocol.

Issue Release: 2024

Hemorrhagic Posterior Reversible Encephalopathy Syndrome in a Pediatric Patient With Acute Lymphoblastic Leukemia: A Case Report.

Issue Release: 2024

A Comparative Study of B Cell Blast Isolation Methods from Bone Marrow Aspirates of Pediatric Leukemia Patients.

Issue Release: 2024

Combination of venetoclax and azacitidine in relapsed/refractory acute B-cell lymphoblastic leukemia: a case series from a single center.

Issue Release: 2024

Linkage of cell division cycle 42 with clinical features, treatment response and survival in adult Philadelphia chromosome negative acute lymphoblastic leukemia.

Issue Release: 2024

Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.

Issue Release: 2024

Outcomes of patients aged ≥26 years with relapsed or refractory B-cell acute lymphoblastic leukemia in ZUMA-3 and historical trials.

Issue Release: 2024

How I treat newly diagnosed acute lymphoblastic leukemia.

Issue Release: 2024

Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p.

Issue Release: 2024

How Do Mutant Genes Affect Organisms?

Can the body repair PAH-induced DNA damage?

How is Cystic Fibrosis Diagnosed?

Can Immunotherapy Cause Genetic Mutations?

What Research is Being Conducted?

Why is Karyotyping Important in the Context of Genetic Mutations?

What Role Does Family History Play?

Can Autosomal Recessive Disorders be Treated or Managed?

What is Hemoglobin Electrophoresis?

What Are the Consequences of Meiosis Errors?

B Cell Acute Lymphoblastic Leukemia (all) - Genetic Mutations

Relevant Publications

Partnered Content Networks

Relevant Topics